Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-09 · accession 0000950170-24-105650 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-11 | 2024-09-09 | MDGL | Sibold William John | Pres, CEO, Dir | S - Sale | $243.83 | -6,363 | 55.9K | -10% | -$1.55M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-09 | S | D | 6,363 | $243.83 | 55,887 | D | — | — |